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SUMMARY 
Although eosinophils are inflammatory cells, there is increasing attention on their 
immunomodulatory roles. For example, murine eosinophils can present antigen to CD4+ 
T helper (Th) cells, but it remains unclear whether human eosinophils also have this 
ability.  This study determined whether human eosinophils present a range of antigens, 
including allergens, to activate Th cells, and characterized their expression of MHC 
class II and co-stimulatory molecules required for effective presentation.  Human 
peripheral blood eosinophils purified from non-allergic donors were pulsed with the 
antigens house dust mite extract (HDM), Timothy Grass extract (TG), or 
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Mycobacterium tuberculosis purified protein derivative (PPD), before co-culture with 
autologous CD4+ Th cells.  Proliferative and cytokine responses were measured, with 
eosinophil expression of HLA-DR/DP/DQ and the co-stimulatory molecules CD40, 
CD80 and CD86 determined by flow cytometry.  Eosinophils pulsed with HDM, TG or 
PPD drove Th proliferation, with the response strength dependent on antigen 
concentration.  The cytokine responses varied with donor and antigen, and were not 
biased towards any particular Th subset, often including combinations of pro- and anti-
inflammatory cytokines.  Eosinophils upregulated surface expression of HLA-
DR/DP/DQ, CD80, CD86 and CD40 in culture, increases that were sustained over 5 
days when incubated with antigens, including HDM, or the major allergens it contains, 
Der p 1 or Der p 2.  Human eosinophils can, therefore, act as effective APC to stimulate 
varied Th cell responses against a panel of antigens including HDM, TG or PPD, an 
ability that may help to determine the development of allergic disease.   
 
INTRODUCTION 
Eosinophil involvement in inflammatory conditions affecting the skin, gastrointestinal 
tract and upper and lower airways is well-documented.1,2 In addition to their role as 
degranulating effector cells, more recent findings emphasize the immunomodulatory 
properties of eosinophils,3 and other important effector functions such as a potential role 
in maintaining host survival in life-threatening respiratory viral infections.4   One 
question that has attracted interest is whether eosinophils can modulate immune 
responses by acting as antigen presenting cells (APC) to stimulate CD4+ helper T (Th) 
cell responses.  It has been known for many years that in vitro culture of eosinophils 
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with GM-CSF, typically added to prevent their apoptosis, can also induce expression of 
MHC Class II,5 which could equip them for antigen presentation.   
 
Consistent with APC function, murine eosinophils home to lymphoid tissue and provide 
a second signal for T cell activation through the expression of key co-stimulatory 
molecules such as CD80 and CD86.6,7  Although it has been demonstrated that human 
eosinophils can express CD86 when taken from hyper-eosinophilic patients,8 or 
stimulated with IL-3,9 it is unclear how commonly, or in what circumstances, they 
display such co-stimulatory molecules.  There are also reports that human eosinophils 
can process and present antigen to activate specific T cells,10 but, again, it remains to be 
established how widespread is such ability in different individuals and for different 
antigens.  Despite the evidence that eosinophils have the potential to act as APC to drive 
Th cell responses and thereby propagate inflammation, 11-13 other findings have 
suggested that this is limited to super-antigens and peptides rather than proteins that 
require processing.6,14   
 
The effects of Th activation are critically dependent on the subset(s) that respond, and 
the associated cytokines they produce.  In type I hypersensitivity responses Th2 cells 
produce cytokines, such as IL-5 and IL-13, 15 that promote eosinophil activation and 
proliferation,16 but in healthy donors the response to common allergens such as Timothy 
grass17 or house dust mite18 is associated with Th cells producing both Th1 and Th2 
cytokines.  However it is not known whether eosinophil antigen presentation 
preferentially supports responses by any particular Th type.   
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To address the unanswered questions about their roles as APC, we performed a 
comprehensive examination of the ability of purified peripheral blood human 
eosinophils to present a variety of protein antigens to autologous CD4+ Th cells.  The 
focus here was on donors with no history of allergy, since we wished to establish the 
ability of eosinophils to contribute to helper activation in the absence of any pre-
existing strong pathogenic Th2 response.  This work is possible because healthy donors 
harbor allergen specific Th cells.19,20  Helper responsiveness was tested to eosinophils 
pulsed with the allergens house dust mite extract (HDM), Timothy Grass extract (TG), 
Der p 1, Der p 2, or the microbial recall antigen Mycobacterium tuberculosis purified 
protein derivative (PPD), with eosinophil expression of MHC Class II molecules and 
the co-stimulatory molecules CD40, CD80 and CD86 characterized.  It was also 
determined whether any Th cytokines elicited by eosinophil antigen presentation 
exhibited a bias towards particular effector or regulatory subsets.  
 
MATERIALS AND METHODS 
Materials 
CD-16 immunomagnetic beads, the Human CD4+T Cell Isolation Kit II and 
magnetically activated separation columns were from Miltenyi Biotec (Surrey, UK).  
HDM (Dermatophagoides pteronyssinus) and TG extracts, (both certified LPS free and 
obtained from NIBSC, UK) were dialyzed using slide-A- Lyzer dialysis cassettes 
(Thermo scientific, UK) for 24 hours and used at a final concentrations of 500—2500 
IU/ml.  PPD (Satens Serum Institute, Denmark) was added to cell cultures at a final 
concentration of 5 μg/ml.  Dermatophagoides pteronyssinus allergens, Der p 1 or Der p 
2 (Indoor Biotechnologies Ltd) were used at final concentrations 10 μg/ml.  All cells 
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were cultured in RPMI 1640 (Labtech International Ltd, UK) supplemented with 
HEPES and 100 IU/ml penicillin, 100 μg/ml streptomycin, L- glutamine 5% (v/v) 
(Gibco, Life Technologies, Paisley, UK) and 5% (v/v) heat-inactivated autologous 
serum, with 10nM granulocyte-macrophage colony-stimulating factor (rhGM-CSF, 
R&D systems, Abingdon, UK).  The latter was essential to prevent eosinophil apoptosis 
during co-culture. The following mAb were used in these studies: HLA-DR/DP/DQ 
(clone TL2.1), CD1a (clone H1149), CD40 (clone5 C3), CD80 (L307.4) and CD86 
(clone 2331) were all from BD Pharmingen, Oxford, UK. Siglec-8 mAb (clone 7CP) 
was from Biolegend, London, UK.  Cytokine levels were measured by Multiplex array 
for IFN-γ, IL-3, IL-6, IL-10, IL-17A and TNF-α (Luminex, Millipore, Watford, UK) 
and by ELISA for IL-9 and IL-13 (Biolegend). 
 
Eosinophil and Th cell Isolation 
Human eosinophils and CD4+ Th cells were purified from individuals with no clinical 
history of allergy or eosinophilia (< 0.5 x 106 eosinophils/ml), and who were not taking 
any medication for allergic disease.  The inclusion of patients with hemochromatosis, 
who were being routinely bled to treat the disease, allowed relatively large numbers of 
eosinophils for some experiments to be collected from whole units of blood in the face 
of normal eosinophil counts.  All subjects gave informed consent and the study was 
approved by the North of Scotland Research Ethics Service (ref 09/S0801/16).  
Eosinophils were purified from samples of peripheral blood using our standard 
technique13 using dextran sedimentation and centrifugation on Percoll gradients 
followed by CD16-dependent negative immunomagnetic selection.  To obtain CD4+ Th 
cells, peripheral blood mononuclear cells (PBMC) were isolated by density gradient 
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centrifugation21 and non-target cells depleted by negative selection following the 
manufacturer’s instructions. 
 
Using these methods, eosinophils and Th cells with respective purities of at least 98% 
were obtained, as expected from previous reports.22  In particular, the eosinophil 
preparations were free from any detectable cells expressing the CD1a, CD14 or CD19 
markers for professional APC types (Fig. S1. see supplementary materials).  All cell 
preparations exhibited greater than 98% viability as assessed by trypan blue exclusion. 
 
Cell cultures 
Eosinophils (5x105/ml) were incubated in culture medium for up to 5 days in the 
presence of rhGM-CSF (10 nM) to inhibit their spontaneous apoptosis as previously 
described,23 with or without the addition of antigens.  When co-cultured with 
autologous CD4+ Th cells, eosinophils were first pulsed with antigens by overnight 
incubation, then washed and added at 5x105/ml in medium containing GM-CSF to the 
Th cells (1x106/ml) for 5 days; these conditions were found to give optimal Th 
responses in pilot experiments (data not shown).  Cultures of autologous PBMC 
(1.25x106/ml), with or without antigen, provided controls for comparison of Th 
responsiveness.  
 
Th cell responses 
Proliferative Th cell responses were determined by incorporation of 3H-thymidine in 
triplicate 100μl volumes withdrawn from cultures 5 days after stimulation as previously 
described, with results presented as CPM.24  Cytokine levels in cultures were measured 
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by bead array for IFN-γ, IL-3, IL-6, IL-10, IL-17A and TNF-α and by ELISA for IL-9 
and IL-13, according to the manufacturers’ instructions.  Cytokine responses >2x 
background in unstimulated wells were considered significant.21  To test the 
dependency of responses on MHC class II25, antigen-pulsed eosinophils were incubated 
with blocking antibody before co-culture with autologous CD4+ Th cells. 
 
Immunostaining and flow cytometry 
Cell surface expression markers were examined using flow cytometry for HLA-DR,-
DP,-DQ (fluorescein isothiocyanate), and co-stimulatory molecules, CD40 (BD Horizon 
V450), CD80 (Alexa Fluor 700), and CD86 (allophycocyanin) using established 
protocols.13  Briefly, eosinophils and CD4+ Th cells were removed from co-culture, 
washed and saturating quantities of primary antibodies or specific isotype controls were 
added to the cells and incubated for 40 min at 4°C in the dark, washed and fixed.  
Human dendritic cells (DC) were identified by staining cells with CD1a 
(allophycocyanin) while eosinophils were identified by staining with a specific marker, 
siglec-8 (phycoerythrin).26  An EBV-transformed B cell line was used as a source of 
cells that stained positively for HLA-DR/DP/DQ, CD40, CD80 or CD86 (Fig. S2, see 
supplementary material).  Multiple panels of conjugated antibodies were used to 
identify the subpopulation of immune cells and the corresponding specific cell surface 
markers. Ten thousand events were collected on flow cytometer, LSRII (BD 
Biosciences) using FACS Diva software (BD Biosciences). Analysis was performed 
using FlowJo software (Treestar, Inc., Ashland, Oreg. USA). In all plots, dead cells, 
cellular debris and cell aggregates were excluded during the gating process. 
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Statistics 
Data were analyzed using GraphPad Prism 6 (GraphPad Software, La Jolla, CA), and 
since D’Agostino-Person Omnibus and Shapiro-Wilk normality tests were failed, non-
parametric methods were used (Wilcoxon-Signed-Rank-test or Mann-Whitney U Test 
as appropriate).  Bonferroni corrections were applied to multiple comparisons.  Data 
were considered to be statically significant if p<0.05, and are expressed as either median 
and interquartile range (IQR), or individual data points if n<4. 
 
RESULTS 
Eosinophils pulsed with antigen induce proliferative Th responses 
We first examined the ability of human eosinophils pulsed with a range of 
concentrations of the allergens HDM or TG, or with our standard concentration of the 
control microbial recall antigen PPD, to induce proliferation by autologous CD4+ Th 
cells after 5 days of co-culture.  In a series of 9 experiments, significant (p<0.001) 
increases in proliferation were observed when eosinophils had been pulsed by pre-
incubation with the allergens HDM (Fig. 1a) or TG (Fig. 1b) at final concentrations of 
1000, 1500 or 2500 IU/ml, compared with medium alone.  The strongest responses were 
induced by HDM or TG at 2500 IU, and this concentration of the allergens was 
therefore used in all subsequent experiments.  Eosinophils pulsed with the control 
antigen PPD also elicited significant proliferation at the standard concentration of 
5 µg/ml (Fig. 1c).  To confirm that responses to each stimulus required the presence of 
both eosinophils and Th cells, proliferation was compared in cultures containing each 
cell type alone or together, with or without antigen pulsing (Fig. 2).  Proliferative 
responses were significant only when both antigen-pulsed eosinophils and Th cells were 
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added, and, strikingly, these responses were similar in size to those seen when 
unfractionated PBMC were stimulated with the respective antigen as a positive control.  
It should be noted that the ability of the eosinophil preparations to drive such strong Th 
cell responses cannot be explained by the presence of contaminating APC, since none 
could be detected by flow cytometry (Fig. S1, see supplementary material).  Control 
analyses also confirmed that proliferative responses in antigen-stimulated co-cultures 
were mediated by Th cells, but not eosinophils (median CD4+ Th cell count increased 
by 30% in HDM stimulated co-cultures after 5 days p=0.016, Wilcoxon signed rank 
test, n=8, versus no increase in median eosinophil numbers).  The ability of Th cells to 
respond to antigen-pulsed eosinophils was MHC class II dependent, since incubating 
HDM-pulsed eosinophils with blocking mAb specific for HLA-DR/DP/DQ25 
significantly (P<0.001) reduced T cell proliferation by 77% (Fig. S3, see supplementary 
material). 
 
Eosinophil expression of MHC class II and co-stimulatory molecules 
Effective APC require expression of both MHC class II and co-stimulatory molecules, 
so we next tested whether cultured eosinophils display HLA-DR/DP/DQ and CD40, 
CD80 and CD86.  Examples of flow cytometric analyses, and graphical summaries of 
data from 9 independent experiments, demonstrate eosinophil expression of HLA-
DR/DP/DQ (Fig. 3) and CD40, CD80 and CD86 (Fig. 4) during 5 day cultures, with or 
without HDM addition.  It can be seen that, within 24 hours, eosinophil expression of 
MHC class II, and the co-stimulatory molecules CD40, CD80 and CD86, was 
significantly increased in all cultures, an effect that may be at least partly due to the 
presence of GM-CSF added to the medium to prevent eosinophil apoptosis.5  However, 
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there was a further effect of HDM.  Addition of the antigen sustained the elevated levels 
of MHC class II, CD40, CD80 and CD86 over the course of the incubation, since, 
without HDM, expression of all the markers fell back by day 5 to levels not 
significantly above those seen at the beginning of the culture. 
 
The HDM preparation is a simple extract, so we next tested whether the major allergens 
it contains, Der p 1 and Der p 2, recapitulate its ability to sustain enhanced expression 
of MHC class II and co-stimulatory molecules by eosinophils.  Eosinophils incubated 
with purified Der p 1 or Der p 2 exhibited similar sustained increases in expression of 
HLA-DR\DP\DQ, CD40, CD80 and CD86 compared with those elicited by the crude 
HDM preparation (Fig. 5).  
 
Cytokine responses induced by eosinophils pulsed with antigen 
Having demonstrated the ability of eosinophils to present antigen to drive Th 
proliferative responses, the question arises as to whether pro- or anti–inflammatory 
cytokines, or cytokines associated with any particular CD4+ subset are produced.  
Signature cytokines for the major subsets Th1 (IFN-γ), Th2 (IL-13), Th9 (IL-9), Treg 
(IL-10), Th17 (IL-17A) and the inflammatory cytokines TNF-α, IL-3 and IL-6, were 
measured in co-cultures of CD4+ Th cells and eosinophils with, or without, pulsing with 
the antigens HDM, TG or PPD.  Different patterns of cytokine response to the antigens 
were seen in cultures from each of the donors tested (n=6), with examples illustrated in 
Figure 6, and all results summarized in Table 1.  It can be seen that antigen-pulsed 
eosinophils are capable of eliciting a wide range of cytokines tested.  Although IL-6 
production was the most frequently seen response, cultures of antigen-pulsed 
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eosinophils could also contain complex mixtures of both pro- and anti-inflammatory 
cytokines, and, overall, there was no clear or consistent bias towards any particular 
cytokine type. 
 
DISCUSSION 
The present study has established the ability of human eosinophils to present a wide 
variety of protein antigens, including allergens, to stimulate proliferative and cytokine 
responses by CD4+ Th cells.  In line with their ability to elicit responses to antigen, 
eosinophils exhibited upregulated MHC class II and costimulatory molecules in culture.  
Since the donors tested here had no clinical history of allergy, the results raise the 
possibility that eosinophils acting as APC can help determine whether Th responses to 
allergen are elicited or become pathogenic. 
 
There is now a substantial body of evidence demonstrating that murine eosinophils 
presenting antigen have the ability to stimulate Th cells, including the induction of 
primary responses, and that they act as true professional APC in homing to lymph 
nodes, where they can interact with Th cells.12  We show here, for the first time, that 
human eosinophils are also effective APC for a variety of protein antigens in vitro, able 
to evoke significant Th proliferative responses comparable in magnitude to those seen 
when paired PMBC samples are challenged with the same antigen.  Thus, human 
eosinophil presentation to Th cells is limited neither to peptide antigens nor super-
antigens that do not require processing, as has been suggested,6,14 but may instead 
contribute to responses against many different proteins.  The question arises as to why 
previous studies have not clearly demonstrated such APC activity by human 
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eosinophils, particularly when this ability would be predicted from murine studies.6,7  
While it is not possible to pinpoint with any confidence which factor, or combination of 
factors, accounts for the great sensitivity of our study versus those carried out several 
years ago in other laboratories, we can offer a number of suggestions.  Our cultures are 
optimised to support proliferative responses by antigen specific T cells present at low 
precursor frequency, with relatively long time courses allowed for responses to develop, 
and supplementation with autologous serum to enhance sensitivity, rather the foetal calf 
serum used elsewhere.  We also exploited polyclonal T cells as detectors of antigen 
presentation by eosinophils, rather than rely on T cell clones raised against other APC 
types.  Whatever the explanation, whether the ability we describe of human eosinophils 
to act as APC in vitro is replicated in vivo, or in patients with hypersensitivity, now 
needs to be established.  It is noteworthy that upregulation of eosinophil MHC Class II 
expression observed in asthma 27, chronic eosinophilic pneumonia 28, and eosinophilic 
esophagitis29 is consistent with such an immune modulatory role.10,12 
 
APC function is dependent on display of MHC class II and costimulatory molecules. 30  
We not only confirm that cultured human eosinophils express HLA-DR/DP/DQ, but 
also show expression of all three major co-stimulatory molecules, CD40, CD80 and 
CD86 by these cells.  Eosinophils in culture require addition of GM-CSF to prevent 
apoptosis, and the presence of this cytokine is likely to have contributed to the APC 
phenotype seen here, since eosinophils purified from the spleens of IL-5 transgenic 
mice were also observed to express MHC Class II, CD40, CD80 and CD86 when 
stimulated with GM-CSF.10  Previous studies of human eosinophils have described 
upregulation of MHC class II and CD86 in response to cytokine or super-antigen 
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exposure,9,28,31 but, to our knowledge, we are the first to report expression of such a 
complete APC surface phenotype in cultured human eosinophils.  Although it could be 
argued that the precise conditions in vitro do not reflect those in vivo, the results 
nevertheless establish that eosinophils have the potential to present antigen very 
effectively, and the induction of APC function by stimuli such as GM-CSF in vivo may 
well represent an important mechanism by which eosinophils influence immune 
responses to allergens.  In addition, GM-CSF was not the only factor upregulating APC 
surface markers, since we demonstrated that the increases in the expression of HLA-
DR/DP/DQ, CD40, CD80 and CD86 were sustained for up to 5 days of co-culture by 
eosinophils stimulated with whole HDM extract or the major HDM allergens Der p 1 
and Der p 2.  A number of studies have identified similar effects of HDM extract, Der p 
1 or Der p 2 on other cell types.  For example, Der p 1 stimulation of monocyte-derived 
DC isolated from donors allergic to HDM increased CD86 expression, while control 
non-allergic subjects had significant increases in CD80 expression32, and another study 
showed that Der p 1 stimulated human peripheral blood DC to increase expression of 
HLA-DR, CD80 and CD86.33  The underlying mechanisms remain to be established, 
but may include proteolytic activity of the allergen,34 or its interaction with pattern 
recognition receptors.  Der p 2 in particular has auto-adjuvant properties due to 
structural and functional homology with MD-2, the lipopolysaccharide-binding 
component of the Toll-like receptor 4 signaling complex.35 
 
The cytokines elicited during responses to antigen play a key role in determining both 
protection from infection, and immune pathology.  Here, eosinophils acting as APC 
supported production of a wide range of cytokines that differed between individuals and 
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antigens, but with no clear preference for any Th response type.  However, our study 
was of cells from donors with no clinical allergic disease, and so the possibility remains 
open that eosinophils may skew helper responses towards the pathogenic Th2 subset in 
patients with overt allergy, or a susceptibility to atopic disease.  The notion that 
eosinophils can drive a variety of Th subsets is supported by a previous study, which 
also tested co-cultures of human peripheral blood eosinophils and autologous CD4+ Th 
cells, and demonstrated both Th1 and Th2 cytokine responses to the super-antigen 
staphylococcal enterotoxin B (SEB).  These workers also demonstrated HLA-DR 
expression by peripheral blood eosinophils isolated from 50% of the subjects, attributed 
to GM-CSF added to cultures, but stimulation with SEB did not induce eosinophil 
expression of CD80 or CD86.36  The reasons for the differences between this result and 
the present study may well reflect the use of antigens versus polyclonal activator for 
stimulation.  Others have described the effect of stimulation with HDM antigen on 
eosinophil function.  For example, HDM stimulation of eosinophils in vitro led to 
production of IL-9 that may promote a Th2 immune response,37 but, although we detect 
this cytokine in some co-cultures of Th cells and antigen-pulsed eosinophils, HDM did 
not elicit the response more frequently than other antigens, and IL-9 was not associated 
with any clear Th subset bias. 
 
Taken together, our data demonstrate that human eosinophils can act as effective APC 
to stimulate Th responses against a variety of antigens, including the allergens HDM or 
TG: a property that may contribute to the regulation of responses in vivo and to 
induction or control of pathology in allergic disease, depending on the cytokines 
elicited.  The findings add to the accumulating evidence that eosinophils possess more 
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complex immunomodulatory roles in allergic disease than previously suspected.  
Furthermore, any ability of HDM, Der p 1 or Der p 2 to act not only as antigens, but 
also to increase eosinophil co-stimulatory molecule expression, may enhance their 
immunogenicity.  Having demonstrated the ability of human eosinophils to present 
antigen, this study opens up new questions as to how important they are in initiating, 
skewing, amplifying or regulating allergic responses in patients. 
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FIGURE LEGENDS 
Figure 1.  Eosinophils pulsed with allergen stimulate Th cell proliferative 
responses.  Panels show proliferation in co-cultures of peripheral blood CD4+ Th cells 
and autologous eosinophils that have been pulsed with the antigens HDM (a), TG (b), or 
PPD (c).  Results are expressed as median CPM and IQR from 9 independent 
experiments (*p < 0.01, Mann-Whitney U-test with Bonferroni correction). 
 
Figure 2.  Eosinophils pulsed with antigen stimulate Th proliferation comparable 
to PBMC responses.  Panels show proliferation in cultures containing peripheral blood 
CD4+ Th cells and autologous eosinophils, either alone or together, with or without 
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pulsing of the eosinophils with the antigens HDM (a), TG (b) or PPD (c).  Proliferation 
in PBMC cultures, either untreated or antigen stimulated, is included for comparison.  
Eo = purified eosinophils, T = purified CD4+ T cells (*p<0.05, Mann Whitney U-test 
with Bonferroni correction). 
 
Figure 3.  Cultured eosinophils express MHC class II.  Representative flow 
cytometric histograms (n=9) demonstate HLA DR/DP/DQ expression by purified 
eosinophils incubated with HDM at day 0 (a) and day 5 (b) of culture (solid line = 
stained cells, dotted line = unstained cells, dashed line = isotype control).  The gate 
indicates the percentage of eosinophils staining positively for HLA-DR/DP/DQ.  HLA-
DR/DP/DQ expression on unstimulated (c) or HDM stimulated (d) eosinophils over 5 
days of culture is summarized in bar charts, with results expressed as median and IQR 
of % eosinophils positive for HLA DR\DP\DQ staining from 9 independent experiments 
(*p < 0.01, Mann Whitney U-test with Bonferroni correction).  
 
Figure 4.  Cultured eosinophils express costimulatory molecules.  Representative 
flow cytometric histograms (n=9) demonstate CD40 (a), CD80 (b) and CD86 (c) 
expression by purified eosinophils incubated with HDM at day 0 (left panels) and day 5 
(right panels) of culture (solid line = stained cells, dotted line = unstained cells, dashed 
line = isotype control).  The gate indicates the percentage of eosinophils staining 
positively for each co-stimulatory molecule.  CD40 (d), CD80 (e) and CD86 (f) 
expression by unstimulated (left panels) or HDM stimulated (right panels) eosinophils 
over 5 days of culture is summarized in the bar charts, with results expressed as median 
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and IQR of % eosinophils positive for each marker from 9 independent experiments (*p 
< 0.01, Mann Whitney U-test with Bonferroni correction). 
 
Figure 5. Der P1 and Der P2 antigens share the ability of HDM to sustain 
eosinophil surface expression of MHC class II and costimulatory molecules.  
Comparision of the effects of incubation with the purified allergens Der p 1 or Der p 2, 
or the allergen extract HDM, on numbers of eosinophils that  express of HLA-
DR\DP\DQ (a), CD40 (b), CD80 (c) and CD86 (d) after 5 days of culture.  Results are 
expressed as median and IQR of % eosinophils positive for each marker from 6 
independent experiments (* p < 0.01, Mann-Whitney U-test with Bonferroni 
correction).  
 
Figure 6.  Production of multiple cytokines in co-cultures of CD4+ Th cells and 
antigen-pulsed eosinophils.  Examples are shown (donors 1 and 5, n=6) of different 
patterns of cytokine secretion by co-cultures of CD4+ Th cells and eosinophils pulsed 
with the antigens HDM, TG or PPD.  
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Table 1: Cytokine production by co-cultures of Th cells and eosinophils presenting antigen. 
 
Cytokine Stimulus S1 S2 S3 S4 S5 S6 
IFN-γ 
HDM      
TG      
PPD      nt 
TNF-α 
HDM      
TG      
PPD      nt 
IL-3 
HDM      
TG      
PPD      nt 
IL-6 
HDM      
TG      
PPD      nt 
IL-9 
HDM      
TG      
PPD      nt 
IL-10 
HDM      
TG      
PPD      nt 
IL-13 
HDM      
TG      
PPD      nt 
 
IL-17 
 
HDM      
TG      
PPD      nt 
 
The table shows whether there is an increase (up arrow, SI>2), decrease (down arrow, 
SI<0.5) or no change (horizontal arrows, SI range 0.5-2) in cytokine production in Th 
cell-eosinophil co-cultures when eosinophils are pulsed with HDM, TG or PPD, 
compared to unpulsed control.  nt=not tested 
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